Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.
Clinical trial NCT00609492 · COMPLETED
Trial details
- NCT number
- NCT00609492
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-03
- Primary completion
- 2008-11-10
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.